Deutsche Bank Reiterates Hold, $22 PT on Omega Healthcare

Deutsche Bank reiterates its Hold rating and $22 target price on Omega Healthcare

following initial thoughts on 4Q11 results. Deutsche Bank says, "Overall, OHI's 4Q results and 2012 outlook were solid, driven by higherthan-expected investment activity while core metrics were stable q/q. However, given the shares' significant outperformance YTD (+12.8% vs +4.8% HC sector avg), we think much of the good news is already priced in. Netnet, a solid Q which includes a 2.5% dividend raise in mid-Jan." OHI closed at $21.39 a share on Monday.